Wuhan, China

Nengyang Shi



 

Average Co-Inventor Count = 13.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Shanghai, CN (2018)
  • Wuhan, CN (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Nengyang Shi

Introduction

Nengyang Shi is a distinguished inventor based in Wuhan, China, who has made significant contributions to the field of pharmaceutical innovation. With a focus on developing novel compounds, he holds two patents that aim to advance the treatment of critical health conditions.

Latest Patents

Nengyang's latest patents showcase his expertise in drug development. One of his notable inventions is a series of BTK inhibitors, which includes compounds and their pharmaceutically acceptable salts, presented in formulas (I), (II), (III), and (IV). These inhibitors are designed to target specific biological pathways, offering new avenues for therapeutic intervention. Another important patent reflects his work on a pyridino[1,2-A]pyrimidone analogue, utilized as an MTOR/PI3K inhibitor. This invention outlines the use of novel pyridino[1,2-α]pyrimidone compounds represented by formula (I) and discusses their application in treating tumors.

Career Highlights

Nengyang Shi has had a notable career in the pharmaceutical industry, having worked with distinguished organizations such as the Hubei Bio-pharmaceutical Industrial Technological Institute and Cisen Pharmaceutical Co., Ltd. His experience in these institutions has contributed to his ability to innovate and drive advancements in drug development.

Collaborations

Throughout his career, Nengyang has collaborated with talented colleagues, including Chengde Wu and Xuehai Wang. These partnerships have enabled him to broaden his research scope and enhance the effectiveness of his inventions in the pharmaceutical sector.

Conclusion

Nengyang Shi stands out as a prolific inventor whose work has significant implications for pharmaceutical research and cancer treatment. With his innovative patents and collaborative spirit, he continues to make strides in enhancing therapeutic options for patients globally. His contributions reflect not only his individual talents but also the collaborative efforts within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…